Haoxi Health Technology (HAO) said Friday it closed a $12 million underwritten follow-on public offering.
The offering covered the sale of 4 million units at $3 per unit, according to the company. Each unit includes one class A ordinary share, one series A warrant to buy one class A ordinary share and one series B warrant to buy four class A ordinary shares, according to the company.
Haoxi Health said it granted the underwriter a 45-day option to buy up to an additional 600,000 units.
Shares of the company were up 3.4% in after-hours activity.
Price: 0.5999, Change: +0.02, Percent Change: +3.43
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments